Understanding Antithrombotic Medications
What Are Antithrombotic Medications?
Antithrombotic medications, often referred to as blood thinners, are crucial in preventing heart attacks and strokes by inhibiting the formation of blood clots. These medications include both anticoagulants and antiplatelet drugs.
Adverse Events Associated with Antithrombotic Medications
Despite their life-saving benefits, antithrombotic medications can lead to serious adverse events, including bleeding in areas such as the skull, stomach, or intestines. A common side effect of these medications is hematuria, which is the presence of blood in the urine. The prevalence and severity of hematuria in patients taking antithrombotic medications remain largely unexplored, as there have been no comprehensive studies on hematuria-related complications until now.
Research Findings on Hematuria-Related Complications
Study Overview
Researchers from the Sunnybrook Health Sciences Centre’s Division of Urology in Toronto, Canada, investigated the incidence of hematuria-related complications among over 800,000 elderly patients. These complications were defined as visits to the emergency department, hospitalizations, or urological procedures aimed at managing hematuria over a period of 7.3 years. The findings were published in the Journal of the American Medical Association.
Results of the Study
The study revealed that patients using blood thinners experienced a higher rate of hematuria-related complications compared to those not on these medications. The most frequently reported complications included urological procedures for hematuria management, followed by hospital admissions and emergency department visits. Notably, the association between antithrombotic use and hematuria-related complications was strongest for emergency room visits, particularly among patients aged 85 and older.
Comparing Older and Newer Blood Thinners
Individual Medication Analysis
The researchers further analyzed the risks associated with each type of blood thinner. Generally, patients on older antithrombotic medications, such as aspirin or warfarin, had lower rates of hematuria-related complications compared to those using newer agents. However, complications were more common with anticoagulants than with antiplatelets.
Newer Oral Anticoagulants
Among the newer oral anticoagulants, dabigatran (Pradaxa) was linked to the lowest rates of hematuria-related complications, while rivaroxaban (Xarelto) had the highest. Antiplatelet medications like clopidogrel (Plavix), ticagrelor (Brilinta), and prasugrel (Effient) also exhibited higher rates of complications when compared to aspirin.
Combination Therapy Risks
Patients requiring both antiplatelet and anticoagulant therapies face an increased risk of hematuria-related complications compared to those taking a single type of antithrombotic agent.
Conclusion
In summary, patients on antithrombotic medications are at a heightened risk for hematuria-related complications. Given that many individuals may need to take these medications for extended periods, if not for life, a careful evaluation of the risks and benefits of antithrombotic therapy is essential. Non-adherence to these treatments is common and can lead to an increased risk of stroke or heart attack.
Reference
Wallis CJD, Juvet T, Lee Y, et al. Association Between Use of Antithrombotic Medication and Hematuria-Related Complications. JAMA. 2017.